EMILY BUCHANAN: Open Payments
NPI 1477171700 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 99 payments from 26 companies in 2025. Trend: 2023 $1,050 · 2024 $1,473 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $271 |
| Novo Nordisk Inc | 10 | $151 |
| Axsome Therapeutics, Inc. | 10 | $135 |
| Viatris Specialty LLC | 6 | $109 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Sumitomo Pharma America, Inc. | 5 | $85 |
| Ardelyx, Inc. | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| Lundbeck LLC | 4 | $74 |
| Eisai Inc. | 3 | $73 |
Products named: YUPELRI, UBRELVY, LEQVIO, QULIPTA, GEMTESA, IBSRELA, XIFAXAN, Auvelity.
Industry payments across TN — which companies pay providers there.
